John Aballi insider trades

Open-market stock purchases and sales by John Aballi, President and CEO at Exagen Inc, from SEC Form 4 filings since Oct 16, 2022.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +212%.

Recent trades

DateStockTradeValue
Oct 16, 2026XGN Exagen IncSold$270K
Mar 12, 2026XGN Exagen IncBought (not open market)—
Mar 12, 2026XGN Exagen IncBought (not open market)$316K
Mar 3, 2026XGN Exagen IncSold$56.8K
Mar 3, 2026XGN Exagen IncBought (not open market)$7.8K
Feb 24, 2026XGN Exagen IncSold$41.3K

Companies traded

  • XGN Exagen Inc: 3 buys, 5 sales, last Oct 16, 2026

Get free alerts when John Aballi files a new trade →